Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jaume Pons Insider Profile
11 Followers
Jaume Pons, PRESIDENT & CSO, Director at ALX Oncology Holdings, holds 604.21K shares in ALX Oncology Holdings (Ticker: ALXO).
Jaume Pons ALX Oncology Holdings (ALXO)PRESIDENT & CSO, Director
ALX Oncology Holdings (ALXO)
PRESIDENT & CSO, Director
Ranked #94,213 out of 98,624 Corporate Insiders
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-66.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
PRESIDENT & CSO, Director
Roles that Jaume Pons holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 07, 2022 - Feb 07, 2023
Return:-20.50%
The most profitable trade made by Jaume Pons
Jaume Pons's Trading History
List of latest transactions for each holding click on a transaction to see Jaume Pons's performance on stock
You May Also Like
Jaume Pons insider profile FAQ
What is the percentage of profitable transactions made by Jaume Pons?
The percentage of profitable transactions made by Jaume Pons is 0%.
What is the average return per transaction made by Jaume Pons?
The average return per transaction made by Jaume Pons is -66.60%.
What stocks does Jaume Pons hold?
Jaume Pons holds: ALXO stocks.
What was Jaume Pons’s latest transaction?
Jaume Pons latest transaction was an Uninformative Sell of $710.00K.
What was Jaume Pons's most profitable transaction?
Jaume Pons’s most profitable transaction was an Informative Buy of ALXO stock on February 7, 2022. The return on the trade was -20.50%.
What is Jaume Pons's role in ALX Oncology Holdings?
Jaume Pons's role in ALX Oncology Holdings is PRESIDENT & CSO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.